Ropinirole

Product NDC: 68151-4073
11-digit product format: 681514073
Labeler code: 68151
Product ID: 68151-4073_91ad82ed-4768-4ac3-b44e-8dc21aa03c35
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: rOPINIRole
Dosage form: TABLET
Route: ORAL
Labeler: Carilion Materials Management
Application: ANDA077852
Marketing category: ANDA
Marketing start: 2008-05-05
Marketing end: 0000-00-00
Substance: ROPINIROLE HYDROCHLORIDE
Active strength: 1 mg/1
Pharmacologic classes: Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68151-4073		I	Inactivated by FDA		2026-08-10
excluded package	package	68151-4073	68151-4073-2	I	Inactivated by FDA		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68151-4073-2	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68151-4073-2	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68151-4073-2	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68151-4073-2	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68151-4073-2	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68151-4073-2	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68151-4073-2	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68151-4073-2	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68151-4073-2	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68151-4073-2	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68151-4073-2	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68151-4073-2	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	68151-4073-2	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	68151-4073-2	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	68151-4073-2	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	68151-4073-2	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	68151-4073-2	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	68151-4073-2	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	68151-4073-2	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	68151-4073-2	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	68151-4073-2	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	68151-4073-2	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 7 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A077852-001	ROPINIROLE HYDROCHLORIDE	ROPINIROLE HYDROCHLORIDE	EQ 0.25MG BASE	TABLET / ORAL	2008-05-05
A077852-002	ROPINIROLE HYDROCHLORIDE	ROPINIROLE HYDROCHLORIDE	EQ 0.5MG BASE	TABLET / ORAL	2008-05-05
A077852-003	ROPINIROLE HYDROCHLORIDE	ROPINIROLE HYDROCHLORIDE	EQ 1MG BASE	TABLET / ORAL	2008-05-05
A077852-004	ROPINIROLE HYDROCHLORIDE	ROPINIROLE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	2008-05-05
A077852-005	ROPINIROLE HYDROCHLORIDE	ROPINIROLE HYDROCHLORIDE	EQ 3MG BASE	TABLET / ORAL	2008-05-05
A077852-006	ROPINIROLE HYDROCHLORIDE	ROPINIROLE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	2008-05-05
A077852-007	ROPINIROLE HYDROCHLORIDE	ROPINIROLE HYDROCHLORIDE	EQ 5MG BASE	TABLET / ORAL	2008-05-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 8 · 287 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077852-001	ROPINIROLE HYDROCHLORIDE	EQ 0.25MG BASE	TABLET / ORAL	2008-05-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077852-002	ROPINIROLE HYDROCHLORIDE	EQ 0.5MG BASE	TABLET / ORAL	2008-05-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077852-003	ROPINIROLE HYDROCHLORIDE	EQ 1MG BASE	TABLET / ORAL	2008-05-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077852-004	ROPINIROLE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	2008-05-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077852-005	ROPINIROLE HYDROCHLORIDE	EQ 3MG BASE	TABLET / ORAL	2008-05-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077852-006	ROPINIROLE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	2008-05-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077852-007	ROPINIROLE HYDROCHLORIDE	EQ 5MG BASE	TABLET / ORAL	2008-05-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077852-001	ROPINIROLE HYDROCHLORIDE	EQ 0.25MG BASE	TABLET / ORAL	2008-05-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077852-002	ROPINIROLE HYDROCHLORIDE	EQ 0.5MG BASE	TABLET / ORAL	2008-05-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077852-003	ROPINIROLE HYDROCHLORIDE	EQ 1MG BASE	TABLET / ORAL	2008-05-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077852-004	ROPINIROLE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	2008-05-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077852-005	ROPINIROLE HYDROCHLORIDE	EQ 3MG BASE	TABLET / ORAL	2008-05-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077852-006	ROPINIROLE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	2008-05-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077852-007	ROPINIROLE HYDROCHLORIDE	EQ 5MG BASE	TABLET / ORAL	2008-05-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077852-001	ROPINIROLE HYDROCHLORIDE	EQ 0.25MG BASE	TABLET / ORAL	2008-05-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077852-002	ROPINIROLE HYDROCHLORIDE	EQ 0.5MG BASE	TABLET / ORAL	2008-05-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077852-003	ROPINIROLE HYDROCHLORIDE	EQ 1MG BASE	TABLET / ORAL	2008-05-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077852-004	ROPINIROLE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	2008-05-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077852-005	ROPINIROLE HYDROCHLORIDE	EQ 3MG BASE	TABLET / ORAL	2008-05-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077852-006	ROPINIROLE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	2008-05-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077852-007	ROPINIROLE HYDROCHLORIDE	EQ 5MG BASE	TABLET / ORAL	2008-05-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077852-001	ROPINIROLE HYDROCHLORIDE	EQ 0.25MG BASE	TABLET / ORAL	2008-05-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077852-002	ROPINIROLE HYDROCHLORIDE	EQ 0.5MG BASE	TABLET / ORAL	2008-05-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077852-003	ROPINIROLE HYDROCHLORIDE	EQ 1MG BASE	TABLET / ORAL	2008-05-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077852-004	ROPINIROLE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	2008-05-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077852-005	ROPINIROLE HYDROCHLORIDE	EQ 3MG BASE	TABLET / ORAL	2008-05-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077852-006	ROPINIROLE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	2008-05-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077852-007	ROPINIROLE HYDROCHLORIDE	EQ 5MG BASE	TABLET / ORAL	2008-05-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077852-001	ROPINIROLE HYDROCHLORIDE	EQ 0.25MG BASE	TABLET / ORAL	2008-05-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077852-002	ROPINIROLE HYDROCHLORIDE	EQ 0.5MG BASE	TABLET / ORAL	2008-05-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077852-003	ROPINIROLE HYDROCHLORIDE	EQ 1MG BASE	TABLET / ORAL	2008-05-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077852-004	ROPINIROLE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	2008-05-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077852-005	ROPINIROLE HYDROCHLORIDE	EQ 3MG BASE	TABLET / ORAL	2008-05-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077852-006	ROPINIROLE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	2008-05-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077852-007	ROPINIROLE HYDROCHLORIDE	EQ 5MG BASE	TABLET / ORAL	2008-05-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077852-001	ROPINIROLE HYDROCHLORIDE	EQ 0.25MG BASE	TABLET / ORAL	2008-05-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077852-002	ROPINIROLE HYDROCHLORIDE	EQ 0.5MG BASE	TABLET / ORAL	2008-05-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077852-003	ROPINIROLE HYDROCHLORIDE	EQ 1MG BASE	TABLET / ORAL	2008-05-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077852-004	ROPINIROLE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	2008-05-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077852-005	ROPINIROLE HYDROCHLORIDE	EQ 3MG BASE	TABLET / ORAL	2008-05-05	`03ed91905a0d…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A077852-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077852-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077852-003	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077852-004	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077852-005	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077852-006	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077852-007	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A077852-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077852-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077852-003	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077852-004	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077852-005	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077852-006	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077852-007	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077852-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077852-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077852-003	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077852-004	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077852-005	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077852-006	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077852-007	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077852-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077852-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077852-003	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077852-004	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077852-005	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077852-006	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077852-007	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dc920868-8845-b908-7ca8-0dee3e345af5	Product name	2	20230123
e24bc1b4-1e16-908e-3d09-29da3ca2fb1f	Product name	2	20170517

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68151-4073-2	2020-01-31	C162847	48780-1	9d75b9d0-78af-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use rOPINIRole Tablets USP safely and effectively. See full prescribing information for rOPINIRole Tablets USP. rOPINIRole Tablets USP, for oral use Initial U.S. Approval: 1997

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68151-4073-2	Ropinirole	1 in 1 PACKAGE	TABLET	1		3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ROPINIROLE HYDROCHLORIDE	ACTIVE INGREDIENT	D7ZD41RZI9	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
ROPINIROLE	ACTIVE MOIETY	030PYR8953	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68151-4073	ROPINIROLE TABLET [CARILION MATERIALS MANAGEMENT]	3	Legacy NDC, 1 package rows	20160806_1cdb9d61-5bbc-4026-a449-fec8c9ce5c65.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
D7ZD41RZI9	ROPINIROLE HYDROCHLORIDE	91374-20-8	ROPINIROLE HYDROCHLORIDE
030PYR8953	ROPINIROLE	91374-21-9	rOPINIRole

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
314208	rOPINIRole HCl 1 MG Oral Tablet	PSN	1cdb9d61-5bbc-4026-a449-fec8c9ce5c65	3
314208	ropinirole 1 MG Oral Tablet	SCD	1cdb9d61-5bbc-4026-a449-fec8c9ce5c65	3
314208	ropinirole 1 MG (as ropinirole hydrochloride) Oral Tablet	SY	1cdb9d61-5bbc-4026-a449-fec8c9ce5c65	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
68151-4073-2	68151407302	1 in 1 PACKAGE	Historical